AACC asks U.S. Senate to prioritize COVID-19 testing

By LabPulse.com staff writers

May 28, 2020 -- The American Association for Clinical Chemistry (AACC) has sent a letter to U.S. Senate leadership with five recommendations to improve testing for the novel coronavirus.

The letter, addressed to Majority Leader Mitch McConnell and Minority Leader Chuck Schumer, emphasized the importance of widespread testing not only for diagnosing and treating patients with COVID-19 but also for launching an appropriate public health response. The AACC sent the letter on May 28 -- as the Senate was negotiating funding for the Heroes Act, the latest bill designed to provide relief during the ongoing COVID-19 pandemic.

The AACC recommendations called for an integrated testing strategy with coordination across federal, state, and local governments. This strategy should include a common terminology, current challenges, necessary testing resources, a plan for acquiring and distributing materials, and benchmarks to measure progress, the letter noted.

The letter also advocated for better supply chain management as many laboratories continue to report delays in obtaining the devices, reagents, swabs, transport media, and personal protective equipment needed to perform COVID-19 testing. It also suggested creating a solution to allow healthcare facilities to report current inventory levels.

Other recommendations included the following:

  • Increase funding for the U.S. Centers for Disease Control and Prevention to help the organization oversee COVID-19 activities and establish necessary public health infrastructure to address the current pandemic as well as future health crises
  • Expand COVID-19 serological and antibody testing to include those who may have already contracted and recovered from the virus
  • Provide financial support for hospitals, commercial laboratories, and other healthcare providers who may have incurred significant revenue losses due to the COVID-19 pandemic

"Thanks to Congress' rapid and comprehensive approach to dealing with the COVID-19 pandemic, the healthcare sector has made significant advances in expanding testing capacity," stated AACC President Carmen Wiley, PhD, in a press statement. "We now urge the Senate to align the Heroes Act with lab experts' recommendations before passing it into law, which is crucial to ensuring that the progress we've made fighting COVID-19 continues."

AACC objects to FDA's at-home virus kit clearance, following go-ahead for Everlywell
The American Association for Clinical Chemistry (AACC) has notified the U.S. Food and Drug Administration (FDA) that it objects to the agency's recent...
AACC provides a steer on antibody testing for novel coronavirus
The American Association for Clinical Chemistry (AACC) is advising that antibody testing for the novel coronavirus should be limited to diagnostics that...
AACC warns coronavirus self-tests vulnerable to flawed specimen collection
The American Association for Clinical Chemistry (AACC) has recommended that the U.S. Food and Drug Administration issue a warning about COVID-19 at-home...
AACC educates on antibody testing for coronavirus and more
With testing in the spotlight during the COVID-19 pandemic, the American Association for Clinical Chemistry (AACC) has created educational videos explaining...
AACC announces 2020 award winners
The American Association for Clinical Chemistry (AACC) has announced the recipients of the 2020 AACC and AACC Academy awards.

Copyright © 2020 LabPulse.com

Last Updated ls 5/28/2020 4:33:36 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current